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Abstract
Lewy body dementia (consisting of dementia with Lewy bodies and Parkinson’s disease
dementia) is a common neurodegenerative disease characterised by visual hallucinations, fluc-
tuating attention, motor disturbances, falls, and sensitivity to antipsychotics. This combin-
ation of features presents challenges for pharmacological management. Given this, we
sought to review evidence for non-pharmacological interventions with patients with Lewy
body dementia and their carers. Bibliographic databases were searched using a wide range
of search terms and no restrictions were placed on study design, language, or clinical setting.
Two reviewers independently assessed papers for inclusion, rated study quality, and extracted
data. The search identified 21 studies including two randomised controlled trials with avail-
able subgroup data, seven case series, and 12 case studies. Most studies reported beneficial
effects of the interventions used, though the only sizeable study was on dysphagia, showing
a benefit of honey-thickened liquids. Given the heterogeneity of interventions and poor qual-
ity of the studies overall, no quantitative synthesis was possible. Overall, identified studies sug-
gested possible benefits of non-pharmacological interventions in Lewy body dementia, but the
small sample sizes and low quality of studies mean no definite recommendations can be
offered. Our findings underscore the clear and urgent need for future research on this topic.
Introduction
Lewy body dementia is a common neurodegenerative disease in older people (Walker et al.
2015). It is responsible for 5–25% of diagnosed cases of dementia (Vann Jones & O’Brien,
2014), giving it a likely prevalence of around 1% in people over 65 years old (Ballard et al.
2013). The disease is characterised by fluctuations in attention and alertness, recurrent visual
hallucinations, and parkinsonian motor features (McKeith et al. 2005). It is broadly considered
to consist of two related disorders – dementia with Lewy bodies and Parkinson’s disease
dementia – that are distinguished by the relative timing of when cognitive and motor symp-
toms appear. Dementia with Lewy bodies is diagnosed if dementia develops either prior to
parkinsonian motor symptoms or within 1 year of their onset. By contrast, Parkinson’s disease
dementia is diagnosed if dementia develops after 1 year of parkinsonian motor symptoms. The
two disorders share a common underlying pathophysiology, but likely vary in the sequence by
which brain areas underpinning cognition and motor function are affected (Aarsland et al.
2009; McKeith, 2009).
Lewy body dementia poses a number of challenges for clinical management that differ from
those of other dementias. People with Lewy body dementia typically experience visual hallu-
cinations and may be more likely to have delusions than people with other types of dementia
(Ballard et al. 1999; Aarsland et al. 2007; Brodaty et al. 2015). These types of symptoms can be
very distressing to both patients and their carers, and are a risk factor for early institutional-
isation (Black & Almeida, 2004; Brodaty et al. 2014). Pharmacological management, however,
is limited because of the condition’s adverse sensitivity to neuroleptics (antipsychotic drugs)
(McKeith et al. 1992; Aarsland et al. 2005; Ballard et al. 2013). Antidepressants also appear
to be poorly tolerated (Culo et al. 2010) with no clear evidence that they are effective for treat-
ing mood disturbances in this population (Ballard et al. 2013; Stinton et al. 2015), though fur-
ther research is needed. At the same time, patients typically have parkinsonian motor
disturbances and treatment responses are limited by the fact that some antiparkinson medica-
tions can exacerbate psychotic symptoms (McKeith et al. 2005). People with Lewy body
dementia are also prone to falls, which further increases the risks of using medications that
exacerbate orthostatic hypotension, impair cognition, or otherwise predispose to falls.
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Finally, people with Lewy body dementia may undergo faster cog-
nitive decline (Rongve et al. 2016), require higher costs of care
(Murman et al. 2003; Boström et al. 2007; Vossius et al. 2014),
result in greater caregiver burden (Svendsboe et al. 2016), and
progress more quickly to death (Oesterhus et al. 2014) than
people with Alzheimer’s disease and other dementias.
Despite these challenges and the relatively high prevalence of
the disease, the evidence base for intervention strategies remains
unclear. A previous systematic review and meta-analysis of
pharmacological treatments for Lewy body dementia identified
a lack of high-quality evidence for commonly used drugs in this
population, though found evidence for efficacy of cholinesterase
inhibitors (Stinton et al. 2015). Another systematic review evalu-
ated the benefits of exercise in Lewy body dementia and likewise
found little high-quality research (Inskip et al. 2016). There is,
however, no synthesis of evidence for non-pharmacological
options more generally for people with Lewy body dementia.
Such options have been shown to be helpful in other types of
dementia (Brodaty & Arasaratnam, 2012; Livingston et al. 2014;
Orgeta et al. 2015), but are likely to be especially important in
Lewy body dementia given the risks of medications in this popu-
lation. In this paper, we addressed this issue and reviewed studies
that assessed non-pharmacological interventions for patients with
Lewy body dementia.
Method
The protocol for this systematic review was registered at
PROSPERO (registration number CRD42016050492).
Eligibility criteria
The review focused on primary research that assessed a non-
pharmacological intervention for either patients with Lewy body
dementia or carers of such patients. The review considered studies
evaluating non-pharmacological interventions in the broader cat-
egories of dementia or Parkinson’s disease if the results of a Lewy
body dementia subgroup were available. Studies that were con-
founded by a concurrent pharmaceutical intervention (i.e. medi-
cation initiated at the same time as a non-pharmacological
intervention or given to one group in a study but not the
other) were excluded. There were no other restrictions on study
design and no requirements for a comparator group. There were
also no restrictions on language, time period, or clinical context
in which the study was conducted.
Search strategy
The search identified studies through bibliographic databases,
trial registers, and the grey literature. Bibliographic databases
and trial registers included the following: Medline (1946–present);
PreMedline, PubMed; EMBASE (1974–present), Scopus, Web of
Science (1900–current); PsychInfo (1806–present); CINAHL
(1981–present); Cochrane libraries: Cochrane database of system-
atic reviews (2005–October 2016), Cochrane central register of
controlled trials (August 2016), Cochrane Methodology register
(3rd–Quarter 2012); other EBM databases: ACP journal club
(1991–September 2016), Database of Abstracts of Reviews of
Effects (1st-quarter 2015), Health technology assessment
(3rd-quarter 2016), and NHS economic evaluation (1st-quarter
2015); Ageline (1978–present); ALOIS; AMED (Allied and
Complementary Medicine; 1985–present); PEDro (Physiotherapy
Evidence Database; 1929–present); Social work Abstracts (1968–
present); and the National Association of Social Workers
(NASW) clinical register (14th edition). The grey literature was
searched using such resources as SIGLE (System for Information
on Grey Literature in Europe), NTIS (National Technical
Information Service) database, and PsychEXTRA (1908–present).
The search strategy used only population and intervention
terms to maximise the likelihood of identifying relevant studies
(comparator and outcome terms were not used). The population
was people with Lewy body dementia or their carers. This was
identified using the search terms: [(Lewy OR Park*) and
Dementia]. Interventions were any non-pharmacological treat-
ment and identified using a wide range of terms: (activit*, acu-
puncture, alternative, animal, aromatherapy, art therapy,
assisted, balance, behav*, bicycle, calisthenics, carer intervention,
caregiver intervention, CBT, Chi gong, cognit*, cognitive behav-
ioral therapy, cognitive behavioural therapy, counsel*, creative
arts, dance, dancing, diet, direct current stimulation, drama,
ECT, educat*, electroconvulsive therapy, enhanc*, environmental
intervention, environmental modification, exercise, flexibility,
humor therapy, humour therapy, hydrotherapy, intervention*,
leisure, light therapy, management, martial arts, massage, medita-
tion, Montessori, multisensory, music, non-pharm*, nonpharm*,
nutrition, occupational therapy, pet therapy, physical activity,
physical therapy, physiotherapy, pilates, psychoeducation, psy-
chol*, psychosocial, psychotherapy, Qi gong, reality orientation,
recreation*, reminiscence, resistance training, run*, sensory, simu-
lated presence, stimulation, Snoezelen, support*, support group*,
swim*, tai chi, therap*, therapeutic activity, TMS, training, train-
ing carers, training caregivers, transcranial magnetic stimulation,
treatment*, validation, weight training, yoga). Searches were con-
ducted on 30 October 2016.
In addition to bibliographic database searches, the reference
lists of papers included in the review and previous systematic
reviews on both Lewy body dementia and non-pharmacological
interventions were checked for relevant papers. Advice was also
sought from experts in the field.
Study selection
Two reviewers (MHC and LQ) independently assessed search
results for inclusion by title and abstract. All articles deemed rele-
vant by either reviewer were obtained in full. Both reviewers then
independently evaluated full-text articles for inclusion. Any dis-
agreements were resolved through discussion or, if necessary,
with a third reviewer (JTO).
Data extraction
Two reviewers independently extracted relevant data from publi-
cations using a standardised form. This included participant
details (e.g. demographics, number, recruitment, clinical context,
dementia severity), intervention type, study design, measures, and
results. Qualitative data were also collated.
The primary outcomes were measures of cognition, function,
neuropsychiatric symptoms, and motor symptoms. The second-
ary outcomes were measures of any other clinically relevant out-
comes, such as quality of life, carer burden, financial costs, other
symptoms (sleep or autonomic disturbances), and objective end-
points (e.g. falls, hospitalisation, institutionalisation, mortality).
Secondary outcomes also included the perceived acceptability of
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https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291717003257
Downloaded from https://www.cambridge.org/core. IP address: 86.182.18.76, on 26 Jan 2018 at 16:36:53, subject to the Cambridge Core terms of use, available at
treatments, reported side effects, and dropout rates (a measure of
treatment acceptability).
Quality assessment
Two reviewers independently assessed study quality and risk of
bias using standardised tools. These included the Effective
Public Health Practice Project Quality Assessment Tool for
Quantitative Studies (Effective Public Health Practice Project,
2007; Armijo-Olivo et al. 2012) and the NICE Methodology
Checklist: Qualitative Studies (NICE, 2016). Any disagreements
were resolved through discussion.
Data synthesis
Although a quantitative synthesis of findings using meta-analytic
techniques was originally intended, this was not possible due to
the small sample sizes and poor quality of the included studies.
As a result, only a descriptive synthesis was provided.
Results
Search results
The search identified 73 093 publications, of which 30 419 were
unique and 42 674 were duplicates. Of these, 76 were considered
by one or both reviewers to be potentially relevant and obtained
in full. In turn, 21 studies were found eligible for inclusion
(a flow diagram in PRISMA format is shown in Fig. 1). The
included studies consisted of 12 case studies (Kung & O’Connor,
2002; Loher et al. 2002; Graff et al. 2006; Cheston et al. 2007;
Huh et al. 2008; Freund et al. 2009; Ciro et al. 2013; Gil-Ruiz
et al. 2013; Tabak et al. 2013; Dawley, 2015; Hsu et al. 2015;
Ricciardi et al. 2015), seven case series (Rasmussen et al. 2003;
Rochester et al. 2009; Takahashi et al. 2009; Ota et al. 2012; Elder
et al. 2016; Yamaguchi et al. 2016) – two of which were reported
in the same paper (Takahashi et al. 2009) – and two randomised
controlled trials (Logemann et al. 2008; Telenius et al. 2015).
Both randomised trials focused on the broader conditions of
dementia and/or Parkinson’s disease but had separate results for a
Lewy body dementia subgroup available. One case report was
reported in two separate papers (Freund et al. 2009; Barnikol
et al. 2010); our descriptive synthesis focused on the more detailed
of these papers (Freund et al. 2009). A further case report on elec-
troconvulsive therapy was excluded (Fujiwara et al. 2004) because of
a concurrent pharmacological intervention. Twelve studies focused
on dementia with Lewy bodies (Kung & O’Connor, 2002;
Rasmussen et al. 2003; Cheston et al. 2007; Huh et al. 2008;
Takahashi et al. 2009; Ota et al. 2012; Ciro et al. 2013; Gil-Ruiz
et al. 2013; Hsu et al. 2015; Telenius et al. 2015; Yamaguchi et al.
2016), eight focused on Parkinson’s disease dementia (Loher et al.
2002; Graff et al. 2006; Logemann et al. 2008; Freund et al. 2009;
Rochester et al. 2009; Tabak et al. 2013; Dawley, 2015; Ricciardi
et al. 2015), and one included patients from both groups (Elder
et al. 2016). A summary of studies is shown in Table 1.
Quality assessment
Of the 21 studies, 19 were rated as poor quality due to their small
sample size, uncertainties about recruitment, and the lack of a
control group. One randomised controlled trial, which focused
on exercise in nursing homes for patients with dementia
(Telenius et al. 2015), was evaluated as poor quality with respect
to Lewy body dementia specifically (it only included four partici-
pants with the condition and these participants did not complete
all tasks) (Inskip et al. 2016). The other randomised controlled
trial (Logemann et al. 2008), which investigated dietary fluid
and postural interventions for dysphagia, was evaluated as mod-
erate quality. This study, however, was limited by its lack of blind-
ing and the fact that it relied on measures of immediate efficacy in
a research setting, without any longer term follow-up or measures
of real-world effectiveness. It was also limited by the absence of a
control group that did not receive a treatment, making it difficult
to establish the absolute effectiveness of the interventions.
Participants
The total number of participants across the included studies was
195. This comprised 44 patients with dementia with Lewy bodies
and 151 patients with Parkinson’s disease dementia (of whom,
132 were from one study; Logemann et al. 2008). Demographic
information was not consistently reported. It was not provided
for the subgroup of 132 patients with Parkinson’s disease demen-
tia in the largest study (Logemann et al. 2008) and for two case
series (Ota et al. 2012; Yamaguchi et al. 2016) – altogether 140
participants. Of the data available (n = 55), the mean age of par-
ticipants was 70.6 years (S.D. = 8.2) and included 27 males and 28
females. Measures of patients’ cognition and dementia severity
were lacking from the majority of reports. Of the 21 studies,
nine recruited participants from nursing homes or hospitals,
five recruited participants from the community, and seven did
not report participants’ residential status. One of the studies
that recruited participants from nursing homes examined the
effect of an intervention on both a patient with dementia with
Lewy bodies and her carers (Huh et al. 2008).
Interventions
Interventions included carer education (Huh et al. 2008), psycho-
logical interventions (for visual hallucinations) (Ota et al. 2012),
physical exercise (Tabak et al. 2013; Telenius et al. 2015), gait cue-
ing (Rochester et al. 2009), environmental modification (Gil-Ruiz
et al. 2013) (for mirrored self-misidentification, a delusion that
usually occurs in the context of dementia; Connors & Coltheart,
2011; Connors et al. 2015), music (Hsu et al. 2015), simulated
presence (Cheston et al. 2007), occupational therapy (Graff
et al. 2006; Ciro et al. 2013), physical therapy (Dawley, 2015),
dietary fluid and postural interventions to prevent aspiration
(Logemann et al. 2008), electroconvulsive therapy (Kung &
O’Connor, 2002; Rasmussen et al. 2003; Takahashi et al. 2009;
Yamaguchi et al. 2016), transcranial magnetic stimulation
(Takahashi et al. 2009), transcranial direct current stimulation
(Elder et al. 2016), and deep brain stimulation (Loher et al.
2002; Freund et al. 2009; Ricciardi et al. 2015). The most studied
interventions were electroconvulsive therapy (four studies) and
deep brain stimulation (three studies).
Effectiveness of interventions
Given the heterogeneity of interventions and the poor quality of
the research evidence, no quantitative synthesis was possible. A
descriptive summary of individual studies is provided in Table 1.
All studies reported some effectiveness of their respective
intervention. The strongest evidence came from the randomised
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control trial that assessed interventions to prevent fluid aspir-
ation in participants with dysphagia (Logemann et al. 2008).
This trial compared honey-thickened fluids, nectar-thickened
fluids, and a chin-down posture in 132 patients with
Parkinson’s disease dementia (see Table 1). It found that the
use of honey-thickened fluids was superior to the other two
methods in preventing fluid aspiration as measured by video-
fluorographic swallow studies.
Four small uncontrolled studies (Kung & O’Connor, 2002;
Rasmussen et al. 2003; Takahashi et al. 2009; Yamaguchi et al.
2016) – involving 22 participants in total – found that electrocon-
vulsive therapy had some effectiveness in treating depression in
dementia with Lewy bodies. In one of these studies, two patients
exhibited confusion immediately after electroconvulsive therapy
(Rasmussen et al. 2003); in another study, an unspecified number
displayed signs of autonomic dysfunction, though without any last-
ing effects (Takahashi et al. 2009). No other adverse events were
reported. Another three case studies of deep brain stimulation
(Loher et al. 2002; Freund et al. 2009; Ricciardi et al. 2015) identi-
fied benefits in either cognition or motor symptoms depending on
the location of stimulation in patients with Parkinson’s disease
dementia. All three studies used different brain locations for stimu-
lation. None of these studies reported adverse effects.
Other individual studies variously reported benefits of carer
education for reducing agitation (Huh et al. 2008); psychological
interventions for reducing distress around visual hallucinations
(Ota et al. 2012); physical exercise to improve gait and function
(Tabak et al. 2013; Telenius et al. 2015); gait cueing to improve
gait speed (Rochester et al. 2009); environmental modification
to reduce the distress associated with mirrored self-
misidentification delusion (Gil-Ruiz et al. 2013); music therapy
to reduce agitation (Hsu et al. 2015); simulated presence to reduce
distress (Cheston et al. 2007); occupational therapy interventions
to improve functional ability (Graff et al. 2006; Ciro et al. 2013);
physical therapy to improve gait (Dawley, 2015); dietary fluid and
postural interventions to prevent aspiration (Logemann et al.
2008); transcranial magnetic stimulation to reduce depression
(Takahashi et al. 2009); and transcranial direct current stimula-
tion to improve attention (Elder et al. 2016) (see Table 1). For
all these studies, however, limitations in their design, including
small sample sizes, lack of blinding, and lack of adequate controls,
mean that it is not possible to rule out confounding, selection
Fig. 1. PRISMA flow chart for study selection. *Two of the studies were reported in the same article.
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Table 1. Studies assessing a non-pharmacological intervention for Lewy body dementia
Study Intervention Design Participants Main outcomes Findings
Logemann
et al. (2008)
Interventions to prevent
aspiration of fluids in
patients with dysphagia
(three conditions:
honey-thickened fluids v.
nectar-thickened fluids v.
chin-down posture; all
patients received all three
interventions)
Randomised
controlled
trial
132 PDD with
dysphagia
(from a
sample of 711
patients with
dysphagia and
either
dementia or
Parkinson
disease)
Aspiration (as
measured by
videofluorographic
swallow studies)
Honey-thickened fluids
were superior to both
nectar-thickened fluids
and chin-down posture
in reducing aspiration.
Overall, 59% of patients
aspirated when given
honey-thickened fluids,
64% of patients
aspirated when given
nectar-thickened fluids,
and 69% of patients
aspirated when put in a
chin-down posture.
Pairwise comparisons
were statistically
significant ( p < 0.01)
Telenius et al.
(2015; data
from Inskip
et al. 2016)
Exercise (high-intensity
functional exercises two
sessions/week for 12
weeks v. control group)
Randomised
controlled
trial
Four DLB (from a
sample of 170
patients with
dementia)
Gait speed, balance,
other physical
measures, function
Patients in the exercise
group showed signs of
improved gait speed. The
small number of
participants with Lewy
body dementia in each
condition and missing
data prevented
between-group statistical
comparisons
Tabak et al.
(2013)
Exercise (stationary cycling;
three sessions/week for 8
weeks)
Case study One PDD (from a
sample of two
patients with
Parkinson
disease)
Cognition, function,
quality of life, gait
speed
The patient showed
improvements in
cognition, quality of life,
and gait speed
Rochester
et al. (2009)
Interventions to improve gait
(auditory cueing of gait
with a metronome and
verbal instructions in a
single session)
Case series Five PDD (from a
sample of nine
patients with
Parkinson
disease)
Gait speed, stride
amplitude
Cues that focused attention
on temporal aspects
(stepping to the
metronome’s beat) and
spatial aspects (taking
large steps) appeared to
improve gait speed and
stride amplitude
Dawley (2015) Physical therapy (Lee
Silverman voice
treatment-big
intervention; eight
sessions over 3 months)
Case study One PDD Gait speed, balance,
function
The patient showed some
improvements in gait
speed, balance, and
functional ability despite
poor compliance with
the intervention
Huh et al.
(2008)
Multi-component
intervention including
carer education (32 × 1 h
sessions) and tailored
environmental
modification
Case study One DLB Agitation, function,
carer burden
The patient displayed less
agitation. The carer
reported less distress.
Functional measures,
although collected, were
not reported
Ota et al.
(2012)
Psychological intervention
for visual hallucinations,
including psychoeducation
and environmental
modification (duration and
details not specified)
Case series Two DLB Anxiety, frequency and
content of
hallucinations
Patients reported reduced
anxiety around
hallucinations and that
hallucinations were less
frequent (abstract only;
details not provided)
Gil-Ruiz et al.
(2013)
Environmental modification
for mirrored
self-misidentification
delusion (reducing the
mirror size and
personalising it with
artwork)
Case study One DLB with
delusion
Signs of the delusion,
patient’s distress at
mirror
The patient did not display
the delusion in front of
the modified mirror
(when the modifications
were inadvertently
removed, the delusion
returned; when the
(Continued )
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Table 1. (Continued.)
Study Intervention Design Participants Main outcomes Findings
modifications were
replaced, the delusion
again subsided)
Hsu et al.
(2015)
Music therapy (one
interactive session tailored
to the patient)
Case study One DLB Agitation Patient showed reduced
agitation and anxiety
after the session
according to the
experimenter
Cheston et al.
(2007)
Simulated presence (two
sessions)
Case study One DLB (from a
sample of six
patients with
dementia)
Distress Patient showed less
distressed behaviour
(e.g. less frequent asking
to go home) and more
prosocial behaviour (e.g.
talking calmly with
others) after the sessions
Ciro et al.
(2013)
Occupational therapy (‘skill
building through
task-oriented motor
practice’; STOMP; five
sessions/week for 2
weeks)
Case study One DLB Function (3 tasks:
ability to stand from
a recliner, put on
eyeglasses, and
brush teeth)
The patient improved in her
abilities to stand from a
recliner and put on her
eyeglasses. The patient,
however, showed no
improvement in her
ability to brush her teeth
Graff et al.
(2006)
Occupational therapy
(system-based
intervention focused on
improving the patient’s
functional abilities and his
carer’s behaviours)
Case study One PDD Function, quality of life,
qualitative reports of
both patient and
carer
The patient showed some
improvement in function
and reported greater
autonomy and quality of
life. His carer reported
improved communication
with the patient and
better understanding of
the condition
Kung &
O’Connor
(2002)
Electroconvulsive therapy
(unilateral; seven sessions)
Case study One DLB Depression, other
neuropsychiatric
symptoms
Patient demonstrated less
depression and fewer
neuropsychiatric
symptoms for 2 weeks
after treatment. These
benefits, however, were
not sustained thereafter
Rasmussen
et al. (2003)
Electroconvulsive therapy
(mostly bilateral, though
details varied with patient)
Case series Seven DLB Depression Participants reported less
depression after
treatment; two
participants also
reported less frequent
hallucinations. Group
data were not reported.
Longer term outcomes
were unclear
Yamaguchi
et al. (2016)
Electroconvulsive therapy
(details not provided)
Case series Six DLB Depression, psychotic
symptoms, motor
function (details not
provided)
Patients showed less
depressive and psychotic
symptoms after
treatment, as well
possibly reduced motor
symptoms
(Abstract only; group data
and details not provided)
Takahashi
et al. (2009)
Electroconvulsive therapy
(bifrontotemporal; six
sessions)
Case series Eight DLB with
depression
Depression Patients reported lower
depression scores on the
Hamilton Depression
Rating Scale after
treatment (before
treatment, mean = 38.0,
S.D. = 5.8; after treatment,
mean = 15.0, S.D. = 9.6;
p < 0.01)
(Continued )
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bias, experimenter expectancy, publication bias, and other causes
for the reported effects.
Discussion
The systematic review identified very little research on non-
pharmacological interventions in Lewy body dementia. No rando-
mised control trials focusing specifically on Lewy body dementia
were identified and the majority of research consisted of case
studies and case series. Of the studies identified, the best quality
evidence came from a randomised control trial that focused on
preventing fluid aspiration in Parkinson’s disease patients with
dysphagia (Logemann et al. 2008). As already noted, however,
even this study was limited by the fact that it only examined
the immediate effects of interventions in an experimental context
and did not assess longer term effectiveness in more naturalistic
Table 1. (Continued.)
Study Intervention Design Participants Main outcomes Findings
Takahashi
et al. (2009)
Transcranial magnetic
stimulation
(dorsolateral prefrontal
cortex bilaterally; 10
sessions)
Case series Six DLB with
depression
Depression Patients reported lower
depression scores on the
Hamilton Depression
Rating Scale after
treatment (before
treatment, mean = 24.0,
S.D. = 8.0; after treatment,
mean = 11.0, S.D. = 5.9;
p < 0.01)
Elder et al.
(2016)
Transcranial direct current
stimulation (single 20 min
session)
Case series Five DLB,
Eight PDD
Neuropsychological
battery focused on
attention and
visuoperceptual
abilities
Patients showed
improvements in some
measures of attention
after treatment (patients
reported more correct
answers on a choice
reaction time task,
dz = 0.83, and showed
faster reaction times on
a digit vigilance task,
dz = 0.80). There were no
changes in other
measures of attention or
visuoperceptual
performance
Freund et al.
(2009; also
described
in Barnikol
et al. 2010)
Deep brain stimulation
(two electrodes in the
nucleus basalis of
Meynert; two electrodes in
the subthalamic nucleus)
Case study One PDD Cognition, motor
symptoms
Patient showed improved
cognition and motor
symptoms depending on
the location stimulated:
stimulating the nucleus
basalis of Meynert was
associated with better
cognition and less apraxia,
whereas stimulating the
subthalamic nucleus was
associated with less
parkinsonian motor
symptoms
Loher et al.
(2002)
Deep brain stimulation
(single electrode in the left
internal segment of globus
pallidus)
Case study One PDD Motor symptoms,
cognition, and
function
The patient’s right-sided
motor symptoms
improved considerably.
The patient’s cognitive
and functional abilities,
however, continued to
decline
Ricciardi et al.
(2015)
Deep brain stimulation
(unilateral stimulation of
the pedunculopontine
nucleus)
Case study One PDD Cognition The patient’s cognition
continued to decline
gradually. After 4 years,
stimulation was turned off
and the patient’s
cognition deteriorated
significantly. Stimulation
was then resumed and the
patient’s cognition
returned to what it was
immediately prior to
switching stimulation off
DLB, dementia with Lewy bodies; PDD, Parkinson’s disease dementia.
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settings. Overall, given the heterogeneity of interventions, small
sample sizes, and poor quality of research, no treatment recom-
mendations can be offered.
The lack of research in this area is in contrast to the large
amount of research on non-pharmacological interventions in
other types of dementia (Brodaty & Arasaratnam, 2012;
Livingston et al. 2014; Orgeta et al. 2015; Livingston &
Cooper, 2017; Seeher & Brodaty, 2017). It is consistent, though,
with what has been found in other systematic reviews on Lewy
body dementia (Hindle et al. 2013; Stinton et al. 2015; Inskip
et al. 2016). Despite the lack of research, however, non-
pharmacological interventions are likely to be important in
the management of Lewy body dementia. As already noted,
pharmacological treatment of psychotic symptoms and move-
ment disturbances in this condition is limited by the difficulties
patients have tolerating first-line medications.
At the same time, there is evidence for the effectiveness of non-
pharmacological interventions for similar symptoms in other condi-
tions. In the case of psychosis, for example, multi-factorial interven-
tions, including physical activity, occupational therapy, and music
therapy, have some evidence of effectiveness in other types of
dementia (Brodaty & Arasaratnam, 2012; Chen et al. 2014). In the
case of motor disturbances, interventions such as exercise and gait
training have been found to be effective in Parkinson’s disease
(Bloem et al. 2015). There is also strong evidence that non-
pharmacological interventions are effective at ameliorating symp-
toms that are common across different dementias (Brodaty &
Arasaratnam, 2012; Livingston et al. 2014; Orgeta et al. 2015;
Seeher & Brodaty, 2017). Caregiver education, training, and support,
for example, have been shown to reduce both carers’ distress and
patients’ neuropsychiatric symptoms (Brodaty & Arasaratnam,
2012; Seeher & Brodaty, 2017). Likewise, psychological interventions,
such as cognitive behavioural therapy, have been shown to reduce
patients’ depression (Orgeta et al. 2015). Finally, organised activities,
music therapy, and sensory stimulation have been shown to reduce
patients’ agitation (Livingston et al. 2014). All of these interventions
could be investigated more systematically in Lewy body dementia.
Altogether, the review highlights the clear and urgent need for
research in this area. Possible barriers to this include challenges
establishing the diagnosis and distinguishing it from other
dementias (McKeith et al. 2005; Vann Jones & O’Brien, 2014);
the limited research resources devoted to Lewy body dementia
as opposed to other neurodegenerative conditions; and the gen-
eral lack of funding for non-pharmacological interventions.
Each of these, however, is not insurmountable. The use of multi-
centre registries or networks of centres with expertise in Lewy
body dementia, for example, could help to address the problem
of recruitment. Given the prevalence of the disease, its dispropor-
tionately high social and economic burden (Murman et al. 2003;
Boström et al. 2007; Vossius et al. 2014; Svendsboe et al. 2016),
and the limited suitability of medications, future research into
non-pharmacological interventions is important to improving
management at both individual and population levels.
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